Bid to prevent gut bacteria triggering Alzheimer’s Australian researchers are hopeful they can one day slow down or halt the disease’s progression, as they embark on a new gut study.
Antipsychotics for dementia raise ‘risk of serious harm’: Study From pneumonia to heart attacks, new research revealed the drugs do more harm than first thought, with the risks highest soon after initiation.
‘Breakthrough’ test for early dementia diagnosis a step closer Use of the blood test is expanding and local experts are excited about the impact it could have in Australia – should it become available.
‘It’s never too early’: Dementia diagnosis in the spotlight SPONSORED: A dementia diagnosis can be difficult for patients and GPs alike, but early interventions are proving key to improving lives.
Brain health and risk reduction: The GP’s role If dementia risk factors can be targeted in early and mid-life, GPs have an opportunity to make a real difference, writes Dr Steph Daly.
Raising dementia awareness through collaboration GPs need to be better equipped with risk reduction tools and to help support patients with dementia, writes Dr Marita Long.
A day in the life of a GP with an interest in dementia Dr Steph Daly writes about what inspired her to care for this often-neglected group, and why she wants more colleagues to join the cause.
In Practice: RACGP Faculty elections commence Nominations are now being accepted and the college is calling on members to step up and help shape the future of general practice.
Drug ‘significantly’ slows Alzheimer’s progression: Study A clinical trial of donanemab has now been peer reviewed and published, indicating it can decelerate decline in the disease’s early stages.
Meta-analysis shows social interaction reduces dementia risk Strong social connections were associated with a lower risk of mild cognitive impairment, dementia and death.